The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications
Abstract
In the past decade our understanding of idiosyncratic drug induced liver injury (IDILI) and the contribution of genetic susceptibility and the adaptive immune system to the pathogenesis of this disease process has grown tremendously. One of the characteristics of IDILI is that it occurs rarely and only in a subset of individuals with a presumed susceptibility to the drug. Despite a clear association between single nucleotide polymorphisms in human leukocyte antigen (HLA) genes and certain drugs that cause IDILI, not all individuals with susceptible HLA genotypes develop clinically significant liver injury when exposed to drugs. The adaptation hypothesis has been put forth as an explanation for why only a small percentage of susceptible individuals develop overt IDILI and severe injury, while the majority with susceptible genotypes develop only mild abnormalities that resolve spontaneously upon continuation of the drug. This spontaneous resolution is referred to as clinical adaptation. Failure to adapt or defective adaptation leads to clinically significant liver injury. In this review we explore the immuno‐tolerant microenvironment of the liver and the mechanisms of clinical adaptation in IDILI with a focus on the role of immune‐tolerance and cellular adaptive responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“transient and self‐limited aminotransferase elevations encountered with drugs like isoniazid and statins (Figure 2) that can resolve with continued dosing, presumably because of metabolic and or immunological adaptation.177,178”
From AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury (2023) · cites this paper as [178]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The genetics of multiple sclerosis: SNPs to pathways to pathogenesis
Oksenberg, J. R., Baranzini, S. E., Sawcer, S., & Hauser, S. L. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2395 · Cited by 347
KNOLLE, P., SCHMITT, E., JIN, S., GERMANN, T., DUCHMANN, R., HEGENBARTH, S., GERKEN, G., & LOHSE, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70508-1 · Cited by 298
Breous, E., Somanathan, S., Vandenberghe, L. H., & Wilson, J. M. (2009) · Hepatology · doi:10.1002/hep.23043 · Cited by 237
Murine hepatic stellate cells veto CD8 T cell activation by a CD54-dependent mechanism
Schildberg, F. A., Wojtalla, A., Siegmund, S. V., Endl, E., Diehl, L., Abdullah, Z., Kurts, C., & Knolle, P. A. (2011) · Hepatology · doi:10.1002/hep.24352 · Cited by 90
Yang, H., Chou, H., Gu, X., Wang, L., Brown, K. E., Fung, J. J., Lu, L., & Qian, S. (2009) · Hepatology · doi:10.1002/hep.23202 · Cited by 71
Chakraborty, M., Fullerton, A. M., Semple, K., Chea, L. S., Proctor, W. R., Bourdi, M., Kleiner, D. E., Zeng, X., Ryan, P. M., Dagur, P. K., et al. (2015) · Hepatology · doi:10.1002/hep.27764 · Cited by 64
Research works printed but not linked: 51
- 10.1034/j.1600-0528.2002.017408.x · DOI · Paper page
- 10.1080/01926230252824699 · DOI · Paper page
- 10.1038/215744a0 · DOI · Paper page
- 10.1016/0022-4804(89)90208-4 · DOI
- 10.1016/0022-3468(94)90297-6 · DOI
- 10.1038/223472a0 · DOI · Paper page
- 10.1016/j.jhep.2015.02.042 · DOI · Paper page
- 10.1053/gast.1996.v110.pm8613007 · DOI · Paper page
- 10.1152/ajpregu.00686.2011 · DOI · Paper page
- 10.1002/hep.510270116 · DOI
- 10.1172/JCI118055 · DOI · Paper page
- 10.1016/0168-8278(95)80433-1 · DOI · Paper page
- 10.1111/j.1432-1033.1987.tb13687.x · doi:10.1111/j.1432-1033.1987.tb13687.x
- 10.1016/0168-8278(90)90222-D · DOI
- Knolle PA, 1999, Endotoxin down‐regulates T cell activation by antigen‐presenting liver sinusoidal endothelial cells, J Immunol, 162, 1401, 10.4049/jimmunol.162.3.1401 · DOI · Paper page
- 10.1016/j.jhep.2004.03.008 · DOI · Paper page
- 10.1002/hep.21498 · DOI · Paper page
- 10.4049/jimmunol.1201937 · DOI
- 10.1084/jem.155.2.605 · DOI
- 10.1016/S1074-7613(94)80016-2 · DOI · Paper page
- Gorczynski RM, 1994, Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells, Immunology, 81, 27
- 10.1046/j.1365-2567.1996.481554.x · DOI
- 10.1097/ACI.0000000000000070 · DOI
- 10.1002/hep.26208 · DOI · Paper page
- 10.1002/hep.26295 · DOI
- 10.1016/S1089-3261(02)00025-9 · DOI · Paper page
- 10.1053/j.gastro.2015.03.006 · DOI · Paper page
- Tsutsui H, 1992, Drug‐specific T cells derived from patients with drug‐induced allergic hepatitis, J Immunol, 149, 706, 10.4049/jimmunol.149.2.706 · DOI
- 10.1002/hep.26077 · DOI · Paper page
- 10.1378/chest.68.2.181 · DOI · Paper page
- 2015 Wiley‐VCH Verlag GmbH & Co. KGaA J Senior L. Urbán VF. Patel RJ. Vaz Hepatic side effects 81 106
- 10.1016/S0016-5085(19)32568-5 · DOI · Paper page
- 10.1080/01926230590888306 · DOI · Paper page
- 10.1111/liv.12836 · DOI
- 10.1038/ng.632 · DOI · Paper page
- 10.1002/hep.27549 · DOI · Paper page
- 10.1021/acs.chemrestox.5b00137 · DOI
- 10.1002/hep.27824 · DOI
- 10.1073/pnas.0904489106 · DOI · Paper page
- 10.1002/hep.20205 · DOI · Paper page
- 10.1016/j.jhep.2008.03.017 · DOI
- 10.1084/jem.174.4.915 · DOI · Paper page
- 10.3109/07853899509002465 · DOI · Paper page
- 10.1126/science.aaa8172 · DOI · Paper page
- 10.1371/journal.pone.0053745 · DOI · Paper page
- 10.1111/jgh.12888 · DOI
- 10.1136/bcr‐2014‐208102 · DOI
- 10.1007/s10637-013-9939-6 · DOI · Paper page
- 10.1007/s10620-012-2140-5 · DOI
- 10.14694/EdBook_AM.2015.35.76 · DOI · Paper page
- 10.3109/14397595.2013.844399 · DOI
Cited by
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Self-citationAndrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
Self-citationCarvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Scientific opinion on the safety of green tea catechins
(ANS), E. P. O. F. A. A. N. S. A. T. F., Younes, M., Aggett, P., Aguilar, F., Crebelli, R., Dusemund, B., Filipič, M., Frutos, M. J., Galtier, P., Gott, D., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5239 · Cited by 317
Metadata
- Authors
- Dara, L., Liu, Z., & Kaplowitz, N.
- Affiliations
- Research Center for Liver Disease Keck School of Medicine University of Southern California Los Angeles CA USA
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2015-11-11
- Volume
- 36
- Issue
- 2
- Pages
- 158-165
- ISSN
- 1478-3223
- 1478-3231
- Cited by
- 127
- References
- 6
- Language
- en
- Funders
- National Institutes of Health (RO1DK067215, P30DK48522, 5U01AA021857‐03)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. https://app.cochat.ai/papers/10.1111/liv.12988
- The paper
- Dara, L., Liu, Z., & Kaplowitz, N. (2016). Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. Liver International. https://doi.org/10.1111/liv.12988
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.